ANJAC has expanded its operations by acquiring Slovenia's HCG, enhancing its portfolio in the nutraceutical market and positioning itself for significant growth.

Information on the Target

ANJAC, a prominent French specialist in cosmetics, health, and wellness, has expanded its portfolio through the acquisition of HCG (Health Chain Group), a European leader in dietary supplements based in Slovenia. HCG is known for its integrated model, managing the entire value chain from ingredient sourcing to finished products. Their diverse range of offerings addresses several therapeutic areas, including iron deficiency, women's health, and bone and joint health, and is available in multiple formats such as liquids, capsules, powders, and soft gels.

HCG operates through three entities – PharmaLinea, Hermes Consilium, and ErgoPharma – which combine research and development, manufacturing, scientific marketing, and compliance support for major private-label clients. This acquisition aligns with ANJAC's strategy to enhance its footprint in the 'Beauty & Health' segment, focusing on a holistic approach to wellness.

Industry Overview in Slovenia

The dietary supplement market in Slovenia is experiencing significant growth, fueled by increasing consumer awareness regarding health and wellness. In recent years, the demand for high-quality nutrit